Current guidelines recommend analysis of five genes: KCNH2, KCNQ1, KCNJ2, KCNJ2, CACNA1C and CACNB2 in the diagnosis of SQTS [116], with the KCNH2 gene as the most cost-effective option [193]. This evidence concerns the gene CACNA1C and Familial short QT syndrome.